ViiV Healthcare remains committed to developing new medicines and investing in innovations that will improve patient’s treatment success and quality of life. We hope you find the ViiV Exchange a valuable resource to learn more about our current medicines, clinical data and prescribing information.
KIVEXA tablets contain abacavir and lamivudine. These are also available as separate medicinal products: ZIAGEN (abacavir) and 3TC (lamivudine). KIVEXA tablets are used together with other antiretrovirals to slow down the progression of human HIV infection. KIVEXA tablets do not cure AIDS or kill the HIV virus, but delays further damage to the immune system by stopping production of new viruses.
Date of approval: August 2021 PM-AU-HVX-WCNT-210003